tiregis comprimate filmate 20 mg
egis pharmaceuticals plc - telmisartanum - comprimate filmate - 20 mg
zytux™ 100 mg/10 ml concentrat pentru soluţie perfuzabilă
aryogen pharmed - rituximabum - concentrat pentru soluţie perfuzabilă - 100 mg/10 ml
zytux™ 500 mg/50 ml concentrat pentru soluţie perfuzabilă
aryogen pharmed - rituximabum - concentrat pentru soluţie perfuzabilă - 500 mg/50 ml
glirid comprimate 2 mg
sandoz pharmaceuticals d.d. - glimepiridum - comprimate - 2 mg
atorvastatin comprimate filmate 10 mg
swiss parenterals pvt.ltd. - atorvastatinum - comprimate filmate - 10 mg
atorvastatin comprimate filmate 20 mg
swiss parenterals pvt.ltd. - atorvastatinum - comprimate filmate - 20 mg
caditor comprimate filmate 10 mg
cadila pharmaceuticals ltd - atorvastatinum - comprimate filmate - 10 mg
caditor comprimate filmate 20 mg
cadila pharmaceuticals ltd - atorvastatinum - comprimate filmate - 20 mg
caditor comprimate filmate 40 mg
cadila pharmaceuticals ltd - atorvastatinum - comprimate filmate - 40 mg
clopidogrel acino
acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - agenți antitrombotici - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.